CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 16 enrolled
Drug / intervention
Acuvue® Oasys MAX 1-Day +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05554640
NCT05554640N/ACompleted

Clinical Performance of Two Daily Disposable Silicone Hydrogel Contact Lenses

Johnson & Johnson Vision Care, Inc.·interventional·Posted Sep 26, 2022·Updated Dec 20, 2023

In Brief

A clinical study evaluating Acuvue® Oasys MAX 1-Day and Dailies Total 1 for Visual Acuity. Completed, enrolled 16 participants across 1 site.

Detailed Summary

This is a subject-masked, randomized, bilateral, 2x2 crossover clinical investigation that will assess lens fit acceptance.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedSep 26, 2022
Enrollment StartOct 24, 2022
Primary CompletionDec 1, 2022
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 3.8 years ago

Interventions

Acuvue® Oasys MAX 1-Daydevice

TEST Lens

Dailies Total 1device

CONTROL Lens